What we're reading, March 28, 2016: Covered California mishap with insured consumers' tax forms; Ted Cruz needs to outline his Obamacare replacement plan; and Google's life sciences startup runs into trouble.
Covered California accidentally told the IRS that thousands of people who had insurance in 2015 were not covered. According to the San Francisco Chronicle, customers of Blue Shield and Kaiser Permanente who were enrolled through Covered California received tax forms saying they did not have health insurance last year. The incorrect forms were sent after the customers received the correct forms that indicated they had been covered.
Although Republican presidential candidate Ted Cruz will undoubtedly want to repeal the Affordable Care Act, he has not been very forthcoming on what he would replace the law with. Republicans are suggesting that Cruz would be smart to offer a replacement plan before the primary in Wisconsin, reported POLITICO. The Wisconsin primary could be pivotal if Cruz hopes to prevent frontrunner Donald Trump from securing the nomination, and a health reform proposal could help Cruz net the state’s 42 delegates.
Google’s life sciences startup is running into trouble. STAT reported that the many of the leaders who launched the company’s attempt to revolutionize medicine have quit. A dozen top managers, scientists, and engineers have left Verily in the past year, some to go to competitors, all because working with the CEO was too challenging. However, Verily continues to attract new talent despite its divisive leader.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More